Phase 2 Study of Ex-vivo Perfusion and Ventilation of Lungs to Assess Transplant Suitability
| Status: | Terminated |
|---|---|
| Conditions: | Bronchitis, Chronic Obstructive Pulmonary Disease, High Blood Pressure (Hypertension), Endocrine, Pulmonary |
| Therapuetic Areas: | Cardiology / Vascular Diseases, Endocrinology, Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 7/15/2018 |
| Start Date: | December 2010 |
| End Date: | March 2013 |
The purpose of this research study is to perfect the technique of EVLP and learn about the
safety of transplanting lungs that have been ventilated (attached to a breathing machine or
ventilator to deliver oxygen) and perfused with a lung perfusion solution (Steen solution™,
made by Vitrolife). This ventilation and perfusion will be done outside the body (ex-vivo) in
a modified cardiopulmonary bypass circuit (the kind of device used routinely during most
heart surgeries). The purpose of performing ex-vivo lung perfusion and ventilation (EVLP) is
to learn how well the lungs work, and whether they are likely safe to transplant.
safety of transplanting lungs that have been ventilated (attached to a breathing machine or
ventilator to deliver oxygen) and perfused with a lung perfusion solution (Steen solution™,
made by Vitrolife). This ventilation and perfusion will be done outside the body (ex-vivo) in
a modified cardiopulmonary bypass circuit (the kind of device used routinely during most
heart surgeries). The purpose of performing ex-vivo lung perfusion and ventilation (EVLP) is
to learn how well the lungs work, and whether they are likely safe to transplant.
Lung Recipient Inclusion Criteria:
- A recipient must meet the following requirement to enroll into the study:
- Requires a single or bilateral lung transplant and is listed for lung transplant at
UNC.
- Male or Female, 18 years of age or older.
- Subject or Subject's Representative provides a legally effective informed consent.
- Recipient does not have HIV, active Hepatitis or is colonized with Burkholderia
cepacia.
- Potential subjects who have undergone previous lung transplants and meet all other
inclusion criteria are eligible for study participation.
Lung Recipient Exclusion Criteria:
- Recipient fails to meet standard of care requirements for lung transplant, or decides
not to participate.
We found this trial at
1
site
Click here to add this to my saved trials
